Clinical trial NCT00848380: Management of Cardiovascular Risk Factors
Official title: Management of Cardiovascular Risk Factors
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cardiovascular Risk Factors
Cardiovascular Diseases
Keywords: Hypertension
hyperlipidemia
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2009-02-20
Enrollment: 1492
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: RETROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients with hypertension and hyperlipidemia and other CV risk factors

Brief summary: This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia


Eligibility criteria: Inclusion Criteria:

* Patients received a anti-hypertension treatment in addition to cholesterol lowering treatment during the observation period
* Patients received a cholesterol lowering treatment in addition to hypertension treatment during the observation period
* Patients received during the observation time new cholesterol lowering and hypertension treatment

Exclusion Criteria:

* Patients received during the observation time only cholesterol lowering or only anti-hypertension treatment

Primary outcomes:
measure: The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia.
timeFrame: Inclusion visit, 6 to 9 months before inclusion visit and / or 12 to 15 months before inclusion visit
Secondary outcomes:
Other outcomes:
Locations:
city: Frick
country: Switzerland
facility: Research Site
state: AG
city: Neuenhof
country: Switzerland
facility: Research Site
state: AG
city: Thun
country: Switzerland
facility: Research Site
state: BE
city: Wynigen
country: Switzerland
facility: Research Site
state: BE
city: Riehen
country: Switzerland
facility: Research Site
state: BS
city: Geneve
country: Switzerland
facility: Research Site
state: GE
city: Le Lignon
country: Switzerland
facility: Research Site
state: GE
city: Meyrin
country: Switzerland
facility: Research Site
state: GE
city: Andeer
country: Switzerland
facility: Research Site
state: GR
city: Ilanz
country: Switzerland
facility: Research Site
state: GR
city: Rorschach
country: Switzerland
facility: Research Site
state: SG
city: St. Gallen
country: Switzerland
facility: Research Site
state: SG
city: Gerlafingen
country: Switzerland
facility: Research Site
state: SO
city: Lohn SO
country: Switzerland
facility: Research Site
state: SO
city: Zuchwil
country: Switzerland
facility: Research Site
state: SO
city: Schwyz
country: Switzerland
facility: Research Site
state: SZ
city: Arbedo
country: Switzerland
facility: Research Site
state: TI
city: Bellinzona
country: Switzerland
facility: Research Site
state: TI
city: Claro
country: Switzerland
facility: Research Site
state: TI
city: Coldrerio
country: Switzerland
facility: Research Site
state: TI
city: Locarno
country: Switzerland
facility: Research Site
state: TI
city: Lugano
country: Switzerland
facility: Research Site
state: TI
city: Muralto
country: Switzerland
facility: Research Site
state: TI
city: Bassins
country: Switzerland
facility: Research Site
state: VD
city: Gland
country: Switzerland
facility: Research Site
state: VD
city: Lausanne
country: Switzerland
facility: Research Site
state: VD
city: Montreux
country: Switzerland
facility: Research Site
state: VD
city: Nyon
country: Switzerland
facility: Research Site
state: VD
city: Zug
country: Switzerland
facility: Research Site
state: ZG
city: Affoltern am Albis
country: Switzerland
facility: Research Site
state: ZH
city: Feldmeilen
country: Switzerland
facility: Research Site
state: ZH
city: Herrliberg
country: Switzerland
facility: Research Site
state: ZH
city: Langnau am Albis
country: Switzerland
facility: Research Site
state: ZH
city: Richterswil
country: Switzerland
facility: Research Site
state: ZH
city: Ruti ZH
country: Switzerland
facility: Research Site
state: ZH
city: Zurich
country: Switzerland
facility: Research Site
state: ZH
Study officials:
References: